About FDA
Percent of CDER advisory committee member positions vacant at the end of the month
Dictionary: Access to state-of-the-art, scientific expert advice to support agency decision making processes is imperative to the FDA advisory committee process. Having the fewest vacancies on our committees allows the agency to have ready access to those experts and supports the ability of FDA to meet its public health mission. For more information about FDA advisory committees, please visit http://www.fda.gov/AdvisoryCommittees/default.htm
Information is current as of December 31, 2012.
Fiscal Year - 2012
| Time | Target | Percent Vacant Positions |
|---|---|---|
| Oct 2011 | 10 | 28 |
| Nov 2011 | 10 | 39 |
| Dec 2011 | 10 | 34 |
| Jan 2012 | 10 | 34 |
| Feb 2012 | 10 | 32 |
| Mar 2012 | 10 | 30 |
| Apr 2012 | 10 | 24 |
| May 2012 | 10 | 23 |
| Jun 2012 | 10 | 27 |
| Jul 2012 | 10 | 34 |
| Aug 2012 | 10 | 34 |
| Sep 2012 | 10 | 36 |
Glossary
Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.







